Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) FCF Margin (2020 - 2025)

IDEAYA Biosciences' FCF Margin history spans 6 years, with the latest figure at 848.06% for Q4 2025.

  • For Q4 2025, FCF Margin rose 90561.0% year-over-year to 848.06%; the TTM value through Dec 2025 reached 675.49%, up 291653.0%, while the annual FY2025 figure was 33.59%, 355842.0% up from the prior year.
  • FCF Margin for Q4 2025 was 848.06% at IDEAYA Biosciences, up from 1753.67% in the prior quarter.
  • Across five years, FCF Margin topped out at 89.52% in Q3 2022 and bottomed at 1753.67% in Q4 2024.
  • The 5-year median for FCF Margin is 363.33% (2023), against an average of 504.63%.
  • The largest annual shift saw FCF Margin tumbled -114730bps in 2021 before it skyrocketed 90561bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 496.62% in 2021, then decreased by -2bps to 505.0% in 2022, then tumbled by -32bps to 665.72% in 2023, then tumbled by -163bps to 1753.67% in 2024, then soared by 52bps to 848.06% in 2025.
  • Per Business Quant, the three most recent readings for IDYA's FCF Margin are 848.06% (Q4 2025), 1753.67% (Q4 2024), and 665.72% (Q4 2023).